TLDR: Record $28B options expiry: December 26 marked history’s largest crypto options settlement event.BTC’s Bullish skew persists: 0.35 put-call ratio shows tradersTLDR: Record $28B options expiry: December 26 marked history’s largest crypto options settlement event.BTC’s Bullish skew persists: 0.35 put-call ratio shows traders

Crypto Options Hit Record $28B Expiry as Bitcoin and Ethereum Face Q4 Pressure

2025/12/26 20:24
3 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

TLDR:

  • Record $28B options expiry: December 26 marked history’s largest crypto options settlement event.BTC’s
  • Bullish skew persists: 0.35 put-call ratio shows traders favor calls despite price weakness.
  • March contracts dominate: Q1 2026 options hold 30% of open interest with OTM calls leading positions.
  • Moderate volatility aids sellers: BTC IV at 40% and ETH at 60% create premium collection opportunities.

The cryptocurrency derivatives market witnessed its largest options expiry on December 26, with nearly $28 billion in notional value settling across major digital assets.  

Bitcoin options accounted for $23.6 billion of this total, while Ethereum contributed $3.71 billion. The settlement data reflects a market grappling with four consecutive months of declining prices, though trading activity suggests continued institutional participation through rollover strategies and block trades.

Bitcoin and Ethereum Options Show Bullish Positioning Despite Price Weakness

Market data from Greeks.live shows 267,000 Bitcoin options contracts expired with a put-call ratio of 0.35. 

This ratio indicates stronger demand for call options compared to puts, suggesting traders maintained bullish positioning despite recent price weakness. The maximum pain point settled at $95,000, well above current trading levels.

Ethereum’s expiry involved 1.28 million contracts with a put-call ratio of 0.45 and maximum pain at $3,100. Both assets have traded below key psychological levels, with Bitcoin falling under $90,000 and Ethereum breaking below $3,000. The fourth quarter marked a particularly challenging period for crypto markets.

Open interest distribution data reveals that 541,500 contracts expired on December 26, with calls representing 66% of the total. Following this settlement, March 2026 quarterly options now hold the largest open interest, comprising over 30% of total positions. 

These contracts consist primarily of out-of-the-money call options, indicating traders are positioning for potential price recovery in the first quarter.

Implied Volatility Levels and Trading Patterns Signal Market Conditions

Implied volatility metrics provide insight into current market expectations and risk pricing. Bitcoin’s main tenor implied volatility averaged approximately 40%, while Ethereum’s stood at 60%. 

Both readings fall within moderate ranges compared to historical levels throughout the year. Multiple factors influenced these volatility readings, including reduced price fluctuations and the Christmas holiday period.

Block trade activity increased notably in both volume and proportion ahead of the settlement date. This pattern typically reflects rollover demand as institutional participants reposition their hedges and speculative positions. 

The elevated block trade activity continued through the settlement process, suggesting sustained institutional engagement despite broader market headwinds.

The current market environment appears favorable for option sellers based on prevailing conditions. Moderate volatility levels combined with subdued price action create opportunities for premium collection strategies. 

However, market sentiment remains cautious following four consecutive monthly declines in both major cryptocurrencies. Post-settlement positioning toward March quarterly options suggests participants anticipate potential market stabilization in early 2026.

The post Crypto Options Hit Record $28B Expiry as Bitcoin and Ethereum Face Q4 Pressure appeared first on Blockonomi.

Market Opportunity
Bitcoin Logo
Bitcoin Price(BTC)
$68,033.36
$68,033.36$68,033.36
-0.69%
USD
Bitcoin (BTC) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09